Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human beta cells against proinflammatory insults
R. S. Dos Santos, D. Guzman-Llorens, A. A. Perez-Serna, A. Nadal, L. Marroqui
This study shows deucravacitinib protects human beta cells from proinflammatory cytokines without affecting their survival or function.
bioRxiv · Dec 27, 2022 · PreprintCell Biology